Renal Advantage will use $206 million of mezzanine debt to fund merger

By Lisa Kerner

Charlotte, N.C., Nov. 16 - Renal Advantage, Inc. announced it will use $206 million of mezzanine debt to fund its merger with Liberty Dialysis LLC, according to a market source.

As previously reported, the company is also planning to use proceeds from a $400 million credit facility to fund the deal that is expected to close by Dec. 31.

The facility consists of a $50 million revolver and a $350 million term loan.

Leverage through the first-lien debt is 3.6 times, and net leverage through the mezzanine debt is 5.6 times.

Brentwood, Tenn.-based Renal Advantage and Mercer Island, Wash.-based Liberty Dialysis are providers of dialysis services.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.